Vaccizone is a biotechnology startup that focuses on exploring advanced techniques for antigen delivery in modern medicine. The company's slogan emphasizes its commitment to developing innovative approaches to enhance the immune system's response against cancer, with the aim of improving treatment efficacy and patient outcomes. Since its establishment in 2019, Vaccizone has been working on technologies for precise antigen delivery, which hold significant promise in the fight against cancer.
Based in Turkey, Vaccizone operates within the Biotechnology, Manufacturing, and Pharmaceutical industries. The startup recently received an Angel Round investment on 28 May 2021, with Keiretsu Forum Turkey being the participating investors. This injection of funding is expected to further support the company's research and development efforts, as well as its overall growth trajectory within the biotech sector.